You are here
Hepatology in Asia 2017 will be highly interactive, with scientific exchange between attendees and expert presenters around the current challenges faced by clinicians in the management of both HBV and HCV in Asia. The latest scientific developments and the impact of these on patient care will be discussed.
Programme key topics:
- Improving long-term outcomes for patients with HBV and HCV
- Understanding why some HCV patients fail to achieve SVR
- How opportunities for cure can be extended to more patients with viral hepatitis across Asia
- Case-based challenges in HBV and HCV
HPIA 2017 will be delivered by an expert faculty through keynote lectures, interactive case-based workshops and a fireside panel discussion.
The meeting is aimed at practising hepatologists, gastroenterologists and infectious disease specialists managing patients with chronic hepatitis B/C in Asia. CME accreditation from EACCME is anticipated; confirmation of credits is pending.